Innocrin Pharmaceuticals Holdings
Durham, US · Founded 2014 · Delaware LLC · 1 known investors
Founders & leadership
TL
Thomas LaundonExecutive
WM
William MooreExecutive
Board
RK
Richard KentBoard director
KW
Kristopher WoodBoard director
SE
S. Edward TorresBoard director
SW
Steven WeinsteinBoard director
FE
DR
Douglas ReedBoard director
AV
Andrew von EschenbachBoard director
RS
Robert SchotzingerBoard director
JR
James RosenBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$42.1M disclosed across 3 rounds · 2014–2017
▶$6MraisedJul 2017 · 7 investors · PharmaceuticalsRule 506(b)
▶$6MraisedJul 2017 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kristopher WoodDirector
- Charles OsborneExecutive Officer
- S. Edward TorresDirector
- Fred EshelmanExecutive Officer, Director
- Andrew von EschenbachDirector
- Douglas ReedDirector
- Robert SchotzingerDirector
- Richard KentDirector
- Offering amount
- $13M
- Amount sold
- $6M
- First sale
- Jul 2017
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$28.1MraisedApr 2015 · 9 investors · PharmaceuticalsRule 506(b)
▶$28.1MraisedApr 2015 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard KentDirector
- Kristopher WoodDirector
- Thomas LaundonExecutive Officer
- S. Edward TorresDirector
- Steven WeinsteinDirector
- Fred EshelmanDirector
- William MooreExecutive Officer, Director
- Andrew von EschenbachDirector
- Robert SchotzingerDirector
- Douglas ReedDirector
- Offering amount
- $28.1M
- Amount sold
- $28.1M
- First sale
- Apr 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$8MraisedDec 2014 · 7 investors · PharmaceuticalsRule 506(b)
▶$8MraisedDec 2014 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Douglas ReedDirector
- James RosenDirector
- Kristopher WoodDirector
- William MooreExecutive Officer, Director
- Thomas LaundonExecutive Officer
- S. Edward TorresDirector
- Steven WeinsteinDirector
- Andrew von EschenbachDirector
- Robert SchotzingerDirector
- Offering amount
- $14M
- Amount sold
- $8M
- First sale
- Nov 2014
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Innocrin Pharmaceuticals Holdings's investors?
- Innocrin Pharmaceuticals Holdings's investors include Eshelman Ventures, LLC.
- How much funding has Innocrin Pharmaceuticals Holdings raised?
- Innocrin Pharmaceuticals Holdings has disclosed $42.1M raised across 3 rounds.
- Where is Innocrin Pharmaceuticals Holdings headquartered?
- Innocrin Pharmaceuticals Holdings is headquartered in Durham, US.